Caldera Medical is a women’s health and medical device company on a singular mission to improve the quality of life for women. The company develops and markets differentiated surgical implants for use in minimally invasive surgical procedures specifically for the treatment of Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP). Caldera Medical products are used by Urogynecologists, Gynecologists, and Urologists worldwide. Caldera Medical launched a Women’s Health Initiative (WHI) to eradicate the incapacitation and suffering of women with SUI and POP. As such, Caldera partners with leading surgeons who travel to impoverished areas around the world to train local doctors to treat women that otherwise would not have access to healthcare. The company set a goal of alleviating the suffering of one million women from incontinence and prolapse by 2025.

Caldera Medical experienced a terrific 2019 in both financial growth and impact deployed. The company was included on the Inc. 5000 based on its 3-year revenue growth of 167%. It was also recognized by the Los Angeles Business Journal as one of the area’s “100 Fastest Growing Private Companies of 2019.” Additionally, the company launched both a new product, and its aforementioned Women’s Health Initiative, within the last 12 months.